| Literature DB >> 32993493 |
Zhongliang Duan1, Juanxiu Qin2, Yao Liu2, Cui Li1, Chunmei Ying3.
Abstract
BACKGROUND: Stenotrophomonas maltophilia (S. maltophilia) is an important opportunistic pathogen that can be isolated in hospitals. With the abuse of broad spectrum antibiotics and invasive surgical devices, the rate of S. maltophilia infection is increasing every year. This study was an epidemiological analysis of the clinical and molecular characteristics of S. maltophilia infection in a Chinese teaching hospital. The goal was to obtain a comprehensive understanding of the status of S. maltophilia infection to provide strong epidemiological data for the prevention and treatment of S. maltophilia infection.Entities:
Keywords: Biofilm; Epidemiology; MLST; Stenotrophomonas maltophilia
Year: 2020 PMID: 32993493 PMCID: PMC7526397 DOI: 10.1186/s12866-020-01985-3
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1The distribution of S. maltophilia in the different departments. The pie graph shows the distribution of the wards, among the top three wards. Blue, red, and yellow represent the ICU, neurosurgery, and emergency internal medicine ward, respectively
The clinical characteristics of the adult and pediatric patients
| Adults( | |
|---|---|
| Age (year, average, range) | 66.3 (16–99) |
| Gender: male | 62 (66.7%) |
| Hypertension | 24 (25.8) |
| Heart disease | 12 (12.9) |
| Malignancy | 25 (26.9) |
| Pulmonary disease | 20 (21.5) |
| Liver disease | 12 (12.9) |
| Leukemia | 5 (5.4) |
| Head trauma | 14 (15.1) |
| ICU | 30 (32.3) |
| Sputum | 81 (87.1) |
| 35 (37.6) | |
| The number of antibiotics ≥3 | 69 (74.2) |
| Cephalosporins | 65 (69.9) |
| Carbapenems | 53 (57.0) |
| β-lactamase Inhibitors | 51 (54.8) |
| Quinolones | 35 (37.6) |
| Glycopeptides | 22 (23.7) |
| Aminoglycosides | 13 (14.0) |
Fig. 2The MLST results of 93 S. maltophilia isolates. This is a neighbor-joining tree analysis for the concatenated data for all seven loci of the 93 isolates. The tree was rooted with the corresponding concatenate
Fig. 3Biofilm formation abilities of S. maltophilia in the different genders and ages. Histogram illustrating the ability of biofilm formation. There are no differences in different genders and ages. The number of isolates that formed strong biofilms, however, was significantly greater than the weak and moderate ones
Drug-resistant rates and the relationship between the drug resistance and biofilm formation
| Antibiotics | Resistant rate | Pearson’s correlation |
|---|---|---|
| Levofloxacin | 4.3% | 0.02 |
| TMP/SMX | 9.7% | 0.04 |
| Minocycline | 0% | NA |
Fig. 4The point mutation of spgM in bacterial isolates with different biofilm formation abilities. The spgM gene mutations in isolates with strong biofilm formation abilities are significantly different from that with the weak ones. The mutated portions of the DNA bases are shown in the red box
Univariate analysis of risk factors of S. maltophilia infections in the ICU
| Items | Patients ( | Control ( | OR(95%CI) | |
|---|---|---|---|---|
| Male (sex) | 23 (76.7%) | 38 (63.3%) | 0.263 | 0.565 (0.208–1.534) |
| Age (years) | 64.8 ± 19.1 | 65.5 ± 16.9 | 0.873 | |
| Leukocyte | 11.5 ± 5.4 | 10.9 ± 4.1 | 0.777 | |
| Neutrophil | 9.4 ± 4.9 | 9.4 ± 3.9 | 0.767 | |
| Lymphocyte | 1.3 ± 0.9 | 0.9 ± 0.4 | 0.012 | |
| Monocyte | 0.7 ± 0.5 | 0.5 ± 0.4 | 0.536 | |
| Albumin | 30.6 ± 4.2 | 28.3 ± 5.7 | 0.033 | |
| Globulin | 29.0 ± 6.4 | 28.2 ± 7.0 | 0.286 | |
| Prealbumin | 129.0 ± 52.3 | 124.8 ± 49.9 | 1.000 | |
| Surgeries | 14 (46.7%) | 27 (45.0%) | 0.496 | 0.724 (0.286–1.835) |
| Organ transplantation | 5 (16.7%) | 9 (15.0%) | 0.987 | 0.990 (0.296–3.310) |
| Malignant tumor | 8 (26.7%) | 15 (25.0%) | 0.894 | 0.933 (0.337–2.585) |
| Hypertension | 7 (23.3%) | 15 (25.0%) | 0.923 | 0.949 (0.328–2.748) |
| Diabetes | 3 (10.0%) | 9 (15.0%) | 0.397 | 0.547 (0.135–2.213) |
| Pulmonary infection | 9 (30.0%) | 16 (26.7%) | 0.990 | 1.007 (0.374–2.712) |
| Cardiopathy | 4 (13.3%) | 9 (15.0%) | 0.841 | 0.875 (0.238–3.213) |
| Liver injury | 4 (13.3%) | 7 (11.7%) | 0.972 | 1.024 (0.272–3.856) |
| Trachea intubation | 12 (40.0%) | 21 (35.0%) | 0.941 | 1.036 (0.406–2.640) |
| Chemotherapy | 2 (6.7%) | 3 (5.0%) | 0.843 | 1.205 (0.189–7.681) |
| Immunosuppressor | 9 (30.0%) | 17 (28.3%) | 0.867 | 0.920 (0.343–2.464) |
| Number of antibiotics | 3.6 ± 1.2 | 3.0 ± 1.1 | 0.029 | |
| Carbapenems | 21 (70.0%) | 40 (66.7%) | 0.731 | 1.187 (0.445–3.167) |
| Cephalosporins | 20 (66.7%) | 45 (75.0%) | 0.604 | 0.771 (0.289–2.059) |
| Quinolones | 16 (53.3%) | 30 (50.0%) | 1.000 | 1.000 (0.396–2.523) |
Multivariate logistic regression analysis associated with S. maltophilia infections in the ICU
| Risk factors | B value | Wals | OR value | 95% CI | ||
|---|---|---|---|---|---|---|
| lower limit | upper limit | |||||
| Lymphocyte | 1.077 | 4.208 | 0.04 | 2.937 | 1.049 | 8.222 |
| Albumin | 0.099 | 3.05 | 0.081 | 1.104 | 0.988 | 1.234 |
| Antibiotics | 0.596 | 5.956 | 0.015 | 1.814 | 1.124 | 2.927 |